Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of BridgeBio Pharma Inc (NASDAQ: BBIO) was $31.76 for the day, down -0.28% from the previous closing price of $31.85. In other words, the price has decreased by -$0.28 from its previous closing price. On the day, 1.68 million shares were traded. BBIO stock price reached its highest trading level at $32.99 during the session, while it also had its lowest trading level at $31.68.
Ratios:
Our analysis of BBIO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.
On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’25 when VIKING GLOBAL INVESTORS LP bought 3,065,616 shares for $34.90 per share.
VIKING GLOBAL INVESTORS LP sold 3,065,616 shares of BBIO for $106,989,998 on Jan 31 ’25. The 10% Owner now owns 22,055,375 shares after completing the transaction at $34.90 per share. On Jan 28 ’25, another insider, STEPHENSON BRIAN C, who serves as the Secretary, Treasurer & CFO of the company, sold 68,000 shares for $36.29 each. As a result, the insider received 2,467,761 and left with 93,758 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 6002322432 and an Enterprise Value of 7477271040. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.56. Its current Enterprise Value per Revenue stands at 34.336 whereas that against EBITDA is -14.664.
Stock Price History:
The Beta on a monthly basis for BBIO is 1.08, which has changed by -0.051236212 over the last 52 weeks, in comparison to a change of 0.21659255 over the same period for the S&P500. Over the past 52 weeks, BBIO has reached a high of $41.04, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 4.11%, while the 200-Day Moving Average is calculated to be 16.31%.
Shares Statistics:
BBIO traded an average of 2.53M shares per day over the past three months and 2660540 shares per day over the past ten days. A total of 188.99M shares are outstanding, with a floating share count of 148.36M. Insiders hold about 21.50% of the company’s shares, while institutions hold 74.45% stake in the company. Shares short for BBIO as of 1736899200 were 20382829 with a Short Ratio of 8.06, compared to 1734048000 on 17124130. Therefore, it implies a Short% of Shares Outstanding of 20382829 and a Short% of Float of 16.56.
